Risks for sudden cardiac and undetermined cause of death among people with HIV in the reprieve primary cardiovascular prevention trial

By sjmartinez • May 28, 2025

deFilippi C, Awwad A, Bloomfield GS, Weir IR, Ribaudo H, Zanni MV, Fichtenbaum CJ, Malvestutto CD, Aberg JA, Diggs MR, Chu SM, Paradis K, MacArthur RD, Pilotto J, Marks K, Van Dam C, Wilkin A, Currier JS, Zhao S, Wiviott SD, Lu MT, Douglas PS, Grinspoon S. Risks for sudden cardiac and undetermined cause of death among people with HIV in the reprieve primary cardiovascular prevention trial. AIDS. 2025 May 23. doi: 10.1097/QAD.0000000000004243. Epub ahead of print. PMID: 40424543.

Tags: electrocardiography, HIV, Infectious Diseases, Publications, Sudden cardiac death

Related Posts

Healthcare provider and health system leader perspectives on barriers to hypertension care in Malawi: insights from integrated and non-integrated HIV care settings

Hagstrom C, Kalande P, Aryal A, Phiri K, van Oosterhout JJ, Talama G, Lungu E, Phiri S, Moucheraud C, Hoffman R. Healthcare provider and health[...]

Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2–LTR Circles Over 12 Weeks

Reed JC, Hall L, McKhann A, Kwak G, Goecker EA, Coombs RW, Chen H, Roa J, Vecchio A, Daar ES, Hunt PW, Marra CM, Campbell[...]

Author Correction: Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns

Zhang TH, Shi Y, Komarova NL, Wodarz D, Kostelny M, Gonzales A, Abbaali I, Chen H, Bresson-Tan G, Dimapasoc M, Harvey W, Oh C, Carmona[...]